Malignant Uterine Neoplasm — Trials

Malignant Uterine Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

3,291 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 824
Recruiting: 457
Ph III recruiting: 55
Growth YoY: −4.6%
Industry share: 24%
Top sponsor: National Cancer Institute (NCI)
Termination share: 25.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (333)

clinicaltrialsPublishedShowing 1,051–1,054 of 1,054 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04227249	3 Year Recurrence Free Survival in Ultra-low-risk Endometrial Cancer(TREE PRO)	not yet recruiting	—	153	Seoul National University HospitalOTHER	0	Jan 14, 2020	clinicaltrials
NCT03249519	Radiation Therapy or Chemoradiation, Interstitial Brachytherapy in Combination With Hyperthermia in Advanced Cervical Cancer	recruiting	N/A	999	University of Erlangen-Nürnberg Medical SchoolOTHER	1